{"database": "lobbying", "table": "lobbying_activities", "rows": [[2340187, "48b3c17c-ffc7-47d6-a37f-92e66f7ffacc", "Q3", "CAPITOL HILL STRATEGIES,  LLC", 91774, "BIOTECHNOLOGY INDUSTRY ORGANIZATION", 2019, "third_quarter", "MMM", "Issues relating to prescription drug pricing, oversight, patents, and intellectual property in Medicare and generally, including proposed reform proposals.  \nIssues relating to biologics and biosimilars in Medicare and generally.", "HOUSE OF REPRESENTATIVES,SENATE", 60000, null, 0, 0, "2019-10-10T16:06:21.397000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2340187"], "units": {}, "query_ms": 22.038972994778305, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}